Perrigo reported $0.6 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 0.60 0.56 0.80 Nov/04
FY2026Q2 Jun/2026 0.50 0.34 0.57 Aug/05
FY2026Q1 Mar/2026 0.43 0.33 0.60 May/06
FY2025Q4 Dec/2025 0.77 0.79 0.36 Feb/26
FY2025Q3 Sep/2025 0.80 0.76 0.81 Nov/05




Eps Change Date
AbbVie USD 3.82 0.17 Sep/2026
Abbott USD 0.53 0.78 Sep/2026
Bayer EUR 0.31 0.64 Sep/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Coherus Biosciences USD -0.43 0.06 Dec/2025
Corcept Therapeutics USD 1.01 0.65 Sep/2026
Dr.Reddys Laboratories INR 11.24 5.91 Sep/2026
Eli Lilly USD 7.48 0.9 Sep/2026
J&J USD 2.7 0.2 Sep/2026
Merck USD 2.49 2.62 Sep/2026
Nestle CHF 2.11 0.03 Jun/2026
Pacira USD 0.7 0.03 Sep/2026
Perrigo USD 0.6 0.1 Sep/2026
Pfizer USD 0.87 0.1 Sep/2026
Phibro Animal Health USD 0.78 0.1 Dec/2025
Prestige Brands USD 0.98 0.25 Jun/2026
Reckitt Benckiser GBP 1.84 0.43 Dec/2025
Sanofi EUR 3.55 1.46 Sep/2026
Supernus Pharmaceuticals USD 0.35 1.36 Sep/2026
Teva Pharmaceutical Industries USD 0.79 0.73 Sep/2026
Xeris Pharmaceuticals USD -0.18 0.19 Jun/2026
Zoetis USD 1.75 0.12 Sep/2026